Royal Sense
Royal Sense (ROYAL) share price was ₹72.00 at the 28 Oct 2026 close; market capitalisation ₹38.53 Cr; P/E (TTM) 48.00; sector Healthcare. The share price fell 70.6% over the year to 28 Oct 2026 (adjusted for splits and bonuses). In the Mar 2026 quarter, revenue was ₹60 Cr, against ₹40 Cr a year earlier and net profit was ₹3 Cr, against ₹4 Cr a year earlier (compared with Mar 2025). Promoters held 62.24% of Royal Sense in Sep 2026, unchanged from Mar 2026. Its Tapetide Score is 40/100 (Weak) as of 28 Oct 2026.
Key Fundamentals
SMEHealthcare Equipment & SuppliesHealthcarePrice-based figures as of 28 Oct 2026, 15:30 IST · TTM
Peer Comparison
Healthcare › Medical Equipment › Medical Equipment & Supplies
| ₹1,463.90 | 47.09 | 14,838 Cr | 4.78 | 0.24% | 10.18% | 13.33% | 2,115 Cr | 313 Cr | |
| ₹26.13 | 68.76 | 1,710 Cr | 3.74 | 0.20% | 8.11% | 12.69% | 373 Cr | 24 Cr | |
| ₹308.20 | 147.46 | 1,640 Cr | 2.58 | 0.66% | 2.26% | 4.82% | 468 Cr | 11 Cr | |
| ₹550.00 | 26.07 | 1,283 Cr | 2.63 | 0.00% | 22.63% | 26.37% | 201 Cr | 34 Cr | |
| ₹178.01 | 31.73 | 980 Cr | 4.03 | 0.00% | 10.83% | 11.51% | 289 Cr | 31 Cr | |
| — | — | 832 Cr | 5.31 | 0.00% | 13.22% | 19.52% | — | — | |
| Royal Sense (this company) | — | 48.00 | 39 Cr | 1.01 | 0.00% | 17.67% | 26.08% | 5 Cr | 1 Cr |
| Median 7 companies | ₹308.20 | 47.55 | 1,283 Cr | 3.74 | 0.00% | 10.83% | 13.33% | 331 Cr | 28 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company. 1 company is not shown because they are not listed on an exchange we cover.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Data confidence 95/100
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Stock is trading at 0.95 times its book value
Weaknesses
1- Though the company is reporting repeated profits, it is not paying out dividend
Technical Indicators
Oscillators
Bullish
Overall
Bearish
Moving Averages
Bearish
Growth Rate
change over 1 year
change over 1 year
change over 1 year Operating margin 9% · Mar 2026
Quarterly Results
| Particulars | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Sales | 11 | 22 | 40 | 43 | 60 |
| Expenses | 6 | 19 | 34 | 38 | 55 |
| Operating Profit | 5 | 3 | 6 | 6 | 5 |
| OPM % | 48% | 14% | 14% | 13% | 9% |
| Other Income | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 | 0 | 0 |
| PBT | 5 | 3 | 6 | 5 | 5 |
| Tax % | 7% | 25% | 29% | 25% | 32% |
| Net Profit | 5 | 2 | 4 | 4 | 3 |
| EPS (₹) | 9.94 | 4.86 | 7.97 | 7.59 | 5.79 |
Profit & Loss
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Sales | 18 | 62 | 103 |
| Expenses | 16 | 53 | 92 |
| Operating Profit | 2 | 9 | 11 |
| OPM % | 13% | 14% | 11% |
| Other Income | 0 | 0 | 0 |
| Interest | 0 | 0 | 1 |
| Depreciation | 0 | 0 | 0 |
| PBT | 2 | 9 | 10 |
| Tax % | 28% | 27% | 28% |
| Net Profit | 2 | 6 | 7 |
| EPS (₹) | 3.24 | 12.74 | 13.36 |
| Div. Payout % | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Equity Capital | 5 | 5 | 5 |
| Reserves | 13 | 23 | 35 |
| Borrowings | 2 | 3 | 13 |
| Other Liabilities | 1 | 5 | 8 |
| Total Liabilities | 21 | 36 | 61 |
| Fixed Assets | 0 | 2 | 2 |
| CWIP | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 |
| Other Assets | 20 | 33 | 59 |
| Total Assets | 21 | 36 | 61 |
Cash Flow
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Operating | -4 | 1 | -13 |
| Investing | -1 | -2 | 0 |
| Financing | 13 | 3 | 5 |
| Net Cash Flow | 9 | 2 | -8 |
| Free Cash Flow | -4 | 0 | -14 |
| CFO/EBITDA | -144 | 21 | -110 |
Ratios
| Particulars | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Debtor Days | 66 | 86 | 101 |
| Cash Conversion Cycle | 66 | 86 | 101 |
| Working Capital Days | 187 | 86 | 126 |
| ROCE % | — | 35% | 26% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Royal Sense insights
52 extracted metrics + investor summaries across FY13–FY26.
Documents
Frequently Asked Questions about Royal Sense
What does Royal Sense Ltd do?
Where is Royal Sense Ltd (ROYAL) listed?
Which sector does Royal Sense Ltd belong to?
What is the market capitalisation of Royal Sense Ltd?
What is the PE ratio of Royal Sense Ltd?
What is the 52-week high and low of Royal Sense Ltd?
What is the Return on Equity (ROE) of Royal Sense Ltd?
Company Information
Incorporated in 2023, Royal Sense Ltd specializes in medical device and pharmaceutical trading.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/544143.md for Royal Sense Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.